The Institute for Cellular Therapeutics,1 the Department of Microbiology and Immunology, University of Louisville, Louisville, Kentucky 402022
Received 28 October 2005/ Returned for modification 5 January 2006/ Accepted 7 April 2006
Adjuvant-induced survival of T cells after antigen activation correlates with increased expression of Bcl-3. Bcl-3 is an NF-
B/I
B family member and has been implicated in transcriptional regulation in several cell types. We tested the ability of mice deficient in Bcl-3 (Bcl-3 KO) to exhibit T-cell adjuvant-induced survival after challenge with the superantigen staphylococcal enterotoxin B (SEB), using lipopolysaccharide (LPS) as a natural adjuvant. These studies showed that Bcl-3 is required for secondary gamma interferon (IFN-
) production by CD8 T cells but not for adjuvant-induced survival effects. Specifically, wild-type and Bcl-3 KO mice exhibited comparable long-term increases in the Vß8+ T-cell populations, indicating no lack of survival in response to adjuvant stimulation in the Bcl-3 KO activated T cells. Ectopic expression of the Bcl-3-related molecules I
B
, I
Bß, and I
B
in SEB-activated T cells increased survival during in vitro culture in the absence of adjuvant, suggesting that these I
B molecules could exert a survival function in antigen-activated T cells in place of Bcl-3. However, Vß8+ CD8 T cells from SEB- plus LPS-treated Bcl-3 KO mice produced less IFN-
upon in vitro restimulation than Vß8+ CD8 T cells from wild-type mice. Therefore, Bcl-3 plays a unique role in the regulation of IFN-
production in this model system.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|